Liquidia (LQDA) Stock Forecast, Price Target & Predictions
LQDA Stock Forecast
Liquidia stock forecast is as follows: an average price target of $22.33 (represents a 100.99% upside from LQDA’s last price of $11.11) and a rating consensus of 'Buy', based on 6 wall street analysts offering a 1-year stock forecast.
LQDA Price Target
LQDA Analyst Ratings
Buy
Liquidia Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Aug 20, 2024 | Jason Gerberry | Bank of America Securities | $23.00 | $9.79 | 134.93% | 107.02% |
Aug 19, 2024 | Kambiz Yazdi | Jefferies | $17.00 | $9.59 | 77.27% | 53.02% |
Aug 19, 2024 | Strong Buy | Raymond James | $27.00 | $9.82 | 174.95% | 143.02% |
May 14, 2024 | Kambiz Yazdi | Jefferies | $23.00 | $11.96 | 92.31% | 107.02% |
Sep 02, 2022 | Needham | $16.00 | $4.86 | 229.22% | 44.01% | |
Sep 01, 2022 | Liana Moussatos | Wedbush | $3.00 | $5.77 | -48.01% | -73.00% |
Jul 20, 2022 | BTIG | $17.00 | $5.42 | 213.65% | 53.02% |
Liquidia Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | - | 4 |
Avg Price Target | - | - | $22.50 |
Last Closing Price | $11.11 | $11.11 | $11.11 |
Upside/Downside | -100.00% | -100.00% | 102.52% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Oct 03, 2024 | Raymond James | Buy | Buy | Hold |
Aug 20, 2024 | BTIG | Buy | Buy | Hold |
Aug 20, 2024 | H.C. Wainwright | Buy | Buy | Hold |
Aug 19, 2024 | Jefferies | Buy | Buy | Hold |
Aug 19, 2024 | Raymond James | Outperform | Strong Buy | Upgrade |
Aug 16, 2024 | Raymond James | Outperform | Initialise | |
Aug 08, 2024 | Needham | Buy | Buy | Hold |
Jul 18, 2024 | Needham | Buy | Buy | Hold |
Jun 25, 2024 | Needham | Buy | Buy | Hold |
Jun 24, 2024 | Oppenheimer | Perform | Initialise | |
May 15, 2024 | Needham | Buy | Buy | Hold |
May 14, 2024 | Jefferies | Buy | Buy | Hold |
Apr 01, 2024 | Needham | Buy | Buy | Hold |
Mar 13, 2024 | Wedbush | Buy | Buy | Hold |
Mar 13, 2024 | Needham | Underperform | Underperform | Hold |
Jan 05, 2024 | Needham | Underperform | Underperform | Hold |
Jan 05, 2024 | Wedbush | Buy | Buy | Hold |
Mar 17, 2023 | Needham | Buy | Buy | Hold |
Sep 01, 2022 | Needham | Buy | Buy | Hold |
Jul 20, 2022 | BTIG | Buy | Buy | Hold |
Liquidia Financial Forecast
Liquidia Revenue Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Sep 19 | Jun 19 | Mar 19 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | $4.53M | $3.68M | $4.79M | $4.49M | $5.36M | $3.17M | $3.92M | $3.49M | $-3.34M | $3.18M | $3.38M | $3.08M | - | $8.07M | - | $169.73K |
Avg Forecast | $28.54M | $15.98M | $6.48M | $4.17M | $4.54M | $4.16M | $9.45M | $4.47M | $4.73M | $4.33M | $4.32M | $3.95M | $3.55M | $3.76M | $3.59M | $3.30M | $3.05M | $2.73M | $2.04M | $951.25K | $644.50K | $683.00K | $925.50K | $116.56K |
High Forecast | $35.21M | $19.72M | $7.99M | $5.14M | $6.06M | $5.13M | $9.45M | $4.47M | $5.61M | $4.33M | $5.32M | $4.87M | $4.38M | $3.76M | $3.59M | $3.30M | $3.05M | $2.73M | $2.04M | $951.25K | $644.50K | $683.00K | $925.50K | $139.87K |
Low Forecast | $23.29M | $13.04M | $5.29M | $3.40M | $3.39M | $3.39M | $9.45M | $4.47M | $3.76M | $4.33M | $3.52M | $3.22M | $2.90M | $3.76M | $3.59M | $3.30M | $3.05M | $2.73M | $2.04M | $951.25K | $644.50K | $683.00K | $925.50K | $93.25K |
# Analysts | 1 | 1 | 1 | 2 | 6 | 3 | 4 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 7 | 13 | 13 | 13 | 15 |
Surprise % | - | - | - | - | - | - | - | - | 0.96% | 0.85% | 1.11% | 1.14% | 1.51% | 0.84% | 1.09% | 1.06% | -1.10% | 1.16% | 1.65% | 3.24% | - | 11.82% | - | 1.46% |
Forecast
Liquidia EBITDA Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Sep 19 | Jun 19 | Mar 19 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 2 | 6 | 3 | 4 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 7 | 13 | 13 | 13 | 15 |
EBITDA | - | - | - | - | - | - | - | - | $-25.86M | $-14.89M | $-22.82M | $-8.31M | $-5.83M | $-7.34M | $-7.90M | $-13.52M | $-11.36M | $-5.53M | $-4.76M | $-7.37M | $-12.34M | $-5.03M | $-12.94M | $-8.63M |
Avg Forecast | $-28.54M | $-15.98M | $-6.48M | $-4.17M | $-4.54M | $-4.16M | $-9.45M | $-6.98M | $-4.73M | $-4.33M | $-4.32M | $-7.47M | $-9.43M | $-3.76M | $-3.59M | $-7.98M | $-3.05M | $-2.73M | $-2.04M | $-7.37M | $-644.50K | $-683.00K | $-8.58M | $-5.16M |
High Forecast | $-23.29M | $-13.04M | $-5.29M | $-3.40M | $-3.39M | $-3.39M | $-9.45M | $-5.58M | $-3.76M | $-4.33M | $-3.52M | $-5.97M | $-7.54M | $-3.76M | $-3.59M | $-6.39M | $-3.05M | $-2.73M | $-2.04M | $-5.90M | $-644.50K | $-683.00K | $-6.87M | $-4.13M |
Low Forecast | $-35.21M | $-19.72M | $-7.99M | $-5.14M | $-6.06M | $-5.13M | $-9.45M | $-8.38M | $-5.61M | $-4.33M | $-5.32M | $-8.96M | $-11.31M | $-3.76M | $-3.59M | $-9.58M | $-3.05M | $-2.73M | $-2.04M | $-8.85M | $-644.50K | $-683.00K | $-10.30M | $-6.19M |
Surprise % | - | - | - | - | - | - | - | - | 5.46% | 3.44% | 5.29% | 1.11% | 0.62% | 1.95% | 2.20% | 1.69% | 3.73% | 2.02% | 2.33% | 1.00% | 19.14% | 7.36% | 1.51% | 1.67% |
Forecast
Liquidia Net Income Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Sep 19 | Jun 19 | Mar 19 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 2 | 6 | 3 | 4 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 7 | 13 | 13 | 13 | 15 |
Net Income | - | - | - | - | - | - | - | - | $-27.45M | - | - | $-13.13M | $-5.97M | $-9.35M | $-9.92M | $-16.94M | - | $-7.28M | $-6.55M | $-9.18M | $-13.42M | $-5.90M | $-13.77M | $-9.67M |
Avg Forecast | $-31.99M | $-38.94M | $-31.58M | $-28.81M | $-29.93M | $-29.27M | $-26.75M | $-7.67M | $-18.54M | $-16.85M | $-12.72M | $-8.20M | $-10.09M | $-13.41M | $-18.15M | $-8.77M | $-9.36M | $-9.17M | $-12.04M | $-9.18M | $-45.61M | $-48.92M | $-9.04M | $-5.79M |
High Forecast | $-24.35M | $-29.64M | $-24.04M | $-21.93M | $-19.95M | $-22.28M | $-20.36M | $-6.13M | $-17.73M | $-12.82M | $-9.68M | $-6.56M | $-8.07M | $-13.41M | $-18.15M | $-7.01M | $-9.36M | $-9.17M | $-12.04M | $-7.35M | $-45.61M | $-48.92M | $-7.23M | $-4.63M |
Low Forecast | $-41.71M | $-50.78M | $-41.18M | $-37.57M | $-37.60M | $-38.16M | $-34.87M | $-9.20M | $-19.34M | $-21.96M | $-16.59M | $-9.84M | $-12.11M | $-13.41M | $-18.15M | $-10.52M | $-9.36M | $-9.17M | $-12.04M | $-11.02M | $-45.61M | $-48.92M | $-10.84M | $-6.94M |
Surprise % | - | - | - | - | - | - | - | - | 1.48% | - | - | 1.60% | 0.59% | 0.70% | 0.55% | 1.93% | - | 0.79% | 0.54% | 1.00% | 0.29% | 0.12% | 1.52% | 1.67% |
Forecast
Liquidia SG&A Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Sep 19 | Jun 19 | Mar 19 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 2 | 6 | 3 | 4 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 7 | 13 | 13 | 13 | 15 |
SG&A | - | - | - | - | - | - | - | - | $17.14M | $10.56M | $9.24M | $7.79M | $6.19M | $6.74M | $6.94M | $12.54M | $8.47M | $4.88M | $4.42M | $5.34M | $2.38M | $2.41M | $3.02M | $2.28M |
Avg Forecast | $257.29M | $144.08M | $58.41M | $37.57M | $40.95M | $37.48M | $85.19M | $40.34M | $42.66M | $39.07M | $38.90M | $35.59M | $2.43M | $33.90M | $32.35M | $29.71M | $27.46M | $24.65M | $18.43M | $8.58M | $5.81M | $6.16M | $8.34M | $1.05M |
High Forecast | $317.44M | $177.76M | $72.06M | $46.35M | $54.61M | $46.24M | $85.19M | $40.34M | $50.56M | $39.07M | $48.00M | $43.91M | $2.91M | $33.90M | $32.35M | $29.71M | $27.46M | $24.65M | $18.43M | $8.58M | $5.81M | $6.16M | $8.34M | $1.26M |
Low Forecast | $210.02M | $117.61M | $47.68M | $30.66M | $30.58M | $30.60M | $85.19M | $40.34M | $33.87M | $39.07M | $31.76M | $29.05M | $1.94M | $33.90M | $32.35M | $29.71M | $27.46M | $24.65M | $18.43M | $8.58M | $5.81M | $6.16M | $8.34M | $840.69K |
Surprise % | - | - | - | - | - | - | - | - | 0.40% | 0.27% | 0.24% | 0.22% | 2.55% | 0.20% | 0.21% | 0.42% | 0.31% | 0.20% | 0.24% | 0.62% | 0.41% | 0.39% | 0.36% | 2.17% |
Forecast
Liquidia EPS Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Sep 19 | Jun 19 | Mar 19 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 2 | 6 | 3 | 4 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 7 | 13 | 13 | 13 | 15 |
EPS | - | - | - | - | - | - | - | - | $-0.42 | - | - | $-0.20 | $-0.10 | $-0.15 | $-0.16 | $-0.32 | - | $-0.14 | $-0.13 | $-0.21 | $-0.72 | $-0.31 | $-0.86 | $-0.83 |
Avg Forecast | $-0.41 | $-0.50 | $-0.40 | $-0.37 | $-0.38 | $-0.37 | $-0.34 | $-0.32 | $-0.24 | $-0.22 | $-0.16 | $-0.16 | $-0.16 | $-0.18 | $-0.24 | $-0.21 | $-0.12 | $-0.12 | $-0.16 | $-0.21 | $-0.60 | $-0.64 | $-0.63 | $-0.34 |
High Forecast | $-0.31 | $-0.38 | $-0.31 | $-0.28 | $-0.25 | $-0.28 | $-0.26 | $-0.25 | $-0.23 | $-0.16 | $-0.12 | $-0.12 | $-0.12 | $-0.18 | $-0.24 | $-0.21 | $-0.12 | $-0.12 | $-0.16 | $-0.21 | $-0.60 | $-0.64 | $-0.63 | $-0.27 |
Low Forecast | $-0.53 | $-0.65 | $-0.53 | $-0.48 | $-0.48 | $-0.49 | $-0.45 | $-0.42 | $-0.25 | $-0.28 | $-0.21 | $-0.21 | $-0.20 | $-0.18 | $-0.24 | $-0.21 | $-0.12 | $-0.12 | $-0.16 | $-0.21 | $-0.60 | $-0.64 | $-0.63 | $-0.41 |
Surprise % | - | - | - | - | - | - | - | - | 1.77% | - | - | 1.23% | 0.63% | 0.86% | 0.67% | 1.54% | - | 1.17% | 0.83% | 0.99% | 1.21% | 0.48% | 1.36% | 2.44% |
Forecast
Liquidia Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
INZY | Inozyme Pharma | $2.94 | $16.00 | 444.22% | Buy |
XFOR | X4 Pharmaceuticals | $0.74 | $3.67 | 395.95% | Buy |
GOSS | Gossamer Bio | $0.87 | $3.75 | 331.03% | Buy |
LRMR | Larimar Therapeutics | $4.32 | $17.00 | 293.52% | Buy |
ABOS | Acumen Pharmaceuticals | $1.96 | $7.00 | 257.14% | Buy |
LYRA | Lyra Therapeutics | $0.18 | $0.50 | 177.78% | Hold |
TERN | Terns Pharmaceuticals | $6.80 | $18.67 | 174.56% | Buy |
KALV | KalVista Pharmaceuticals | $8.65 | $22.67 | 162.08% | Buy |
LEGN | Legend Biotech | $34.68 | $89.60 | 158.36% | Buy |
AGEN | Agenus | $2.96 | $7.33 | 147.64% | Hold |
IMCR | Immunocore | $29.40 | $70.20 | 138.78% | Buy |
LQDA | Liquidia | $11.31 | $22.33 | 97.44% | Buy |
AMLX | Amylyx Pharmaceuticals | $4.28 | $8.25 | 92.76% | Buy |
GERN | Geron | $3.93 | $6.83 | 73.79% | Buy |
PCVX | Vaxcyte | $89.86 | $148.80 | 65.59% | Buy |
REPL | Replimune Group | $11.72 | $19.00 | 62.12% | Buy |
BMRN | BioMarin Pharmaceutical | $67.19 | $94.43 | 40.54% | Buy |
MIRM | Mirum Pharmaceuticals | $42.65 | $57.00 | 33.65% | Buy |
NRXP | NRx Pharmaceuticals | $1.64 | $2.00 | 21.95% | Buy |
UTHR | United Therapeutics | $379.69 | $440.40 | 15.99% | Buy |
TECH | Bio-Techne | $75.27 | $82.33 | 9.38% | Buy |
KRON | Kronos Bio | $0.96 | $1.00 | 4.17% | Buy |